Dr. Laura Cubit conducts comprehensive developmental and diagnostic evaluations for children from infancy through adolescence, including autism evaluations. She also provides Parent-Child Interaction Therapy for children and their families. Dr. Cubit supervises clinical trainees and research staff.
Dr. Young’s translational research program aims to understand mechanisms underlying interstitial and rare lung diseases and develop new strategies to treat these disorders. Her laboratory focuses on the roles of epithelial cells in alveolar homeostasis, injury, and repair.
Dr. Zampella’s research focuses on quantifying movement differences in autism and the role of movement in social communication. She is particularly interested in leveraging technology and dyadic paradigms to capture bidirectional interpersonal movement cues as they unfold in natural contexts.
Dr. Goldberg's research program focuses on investigating cerebral cortical circuit function and dysfunction in neurodevelopmental disorders. Using a variety of research techniques, Dr. Goldberg has a specific research interest in the workings of neuron subtype called GABAergic inhibitory interneuron and the role of interneuron dysfunction in disease.
Dr. Minturn's primary clinical and research focus is the development of early-phase clinical trials targeting the molecular drivers of brain/spinal cord tumors. She also focuses on late effects of tumor-directed therapies on the developing nervous system and neurocognitive effects of treatment.
Dr. Kurre's laboratory has longstanding expertise in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With training in transplantation and hematopoietic stem cell biology, he hopes to improve the understanding of the progressive hematopoietic failure in patients with bone marrow failure and FA, broaden diagnostic approaches, and develop next generation therapies.
Dr. Bennett’s research interests include screening for medical and behavioral co-morbidities in individuals with developmental disabilities, with specific interest in improving screening and outcome measures for children with autism spectrum disorder.
The National Institutes of Health (NIH) is considering the possibility of developing a Common Fund program to characterize the human virome to yield greater understanding of the viruses we harbor and their impact on immune function and human health.